Evidence map›Paper›PMID 42526165›Full record

ArticleHematology, transfusion and cell therapy2026

Genetic profiles and hematological characteristics of the α-Hb variant Hb Chumphae (HBA2:c.32T>A) in association with -

Patcharin Sihathip, Wibhasiri Srisuwan, Thitima Sumphanapai, Surada Satthakarn, Tabtim Ngokwongs, Sitthichai Panyasai

Abstract read
In one paragraph

Article in Hematology, transfusion and cell therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Patcharin SihathipThalassemia Center, Khonkaen Hospital, Khonkaen, Thailand.
Wibhasiri SrisuwanDepartment of Medical Technology, School of Allied Health Sciences, University of Phayao, Phayao, Thailand.
Thitima SumphanapaiDepartment of Medical Technology, School of Allied Health Sciences, University of Phayao, Phayao, Thailand.
Surada SatthakarnFaculty of Allied Health Sciences, Burapha University, Chonburi, Thailand.
Tabtim NgokwongsDepartment of Medical Technology, Samsung Hospital, Khonkaen, Thailand.
Sitthichai PanyasaiDepartment of Medical Technology, School of Allied Health Sciences, University of Phayao, Phayao, Thailand. Electronic address: sitthichai.pa@up.ac.th.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveHemoglobin (Hb) variants and thalassemia interactions create complex syndromes, complicating diagnosis. This study aimed to characterize the molecular basis, genetic profile, and potential hematological features of a rare α-hemoglobin variant.

methodsA 44-year-old Thai male presented with unspecified chronic anemia with hepatosplenomegaly. Hematological data were obtained using a standard automated cell counter. Hemoglobin analysis was performed using high-performance liquid chromatography and capillary electrophoresis. Mutational and globin haplotypes were analyzed using polymerase chain reaction and sequencing. The pathogenicity of the mutant gene was predicted, and novel diagnostic methods based on allele-specific polymerase chain reaction were developed.

resultsHematological analysis revealed the following: red blood cell count, 1.74 × 10¹²/L; hemoglobin, 3.7 g/dL; hematocrit, 17%; mean corpuscular volume, 84.7 fL; mean corpuscular hemoglobin, 21.3 pg; mean corpuscular hemoglobin concentration, 25.1 g/dL; and red cell distribution width, 40.5%. Further, Hb A

conclusionsThe presence of Hb Chumphae in combination with α

Indexed as

AnemiaHb ChumphaeHemoglobinopathiesThalassemiaα-globin variant

Identifiers

PMID42526165
PMCPMC13449913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.